Axis Shield gets FDA approval for diagnostic

Axis Shield (LSE:ASD) received FDA marketing approval for %CDT, a diagnostic to detect alcohol-related disease. The product, already approved in Europe, will be marketed in the U.S. by Bio-Rad (BIO.A)...